QTHCPX Mutual Fund

QTHCPX Mutual Fund

See how much of QTHCPX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
-
Expense Ratio
0.92%
Dividend Yield (Current)
-
Holdings
0
Inception Date
Apr 30, 2008
Fund Family
Thrivent Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

1 Year+25.42%
3 Year+6.87%
5 Year+3.85%
10 Year+8.22%

Asset Allocation

Stocks: 99.02%
Cash: 0.13%
Other: 0.85%
See how much of QTHCPX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.15.76%
JNJJohnson & Johnson - Common9.04%
ABBVAbbvie Inc.6.84%
UNHUnitedhealth Group Incorporated6.72%
MRKMerck & Company Inc4.20%
Top 10 Concentration: 57.47%Report Date: Jun 30, 2026
Download all 46 holdings for QTHCPX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

QTHCPX Mutual Fund Overview

QTHCPX Mutual Fund (Thrivent Healthcare Portfolio) is managed by Thrivent Funds. QTHCPX expense ratio is 0.92%, sectors including Health Care, Financials. Inception date: 2008-04-30.

QTHCPX performance shows data across multiple time periods. The 1-year return is 25.42% and the 5-year return is 3.85%.

QTHCPX top holdings include Eli Lilly & Co. (15.8%), Johnson & Johnson - Common (9.0%), Abbvie Inc. (6.8%), Unitedhealth Group Incorporated (6.7%), Merck & Company Inc (4.2%). Go to all QTHCPX holdings, QTHCPX sectors, or QTHCPX dividends.

QTHCPX can be compared against other funds. Use QTHCPX overlap to find shared positions, or QTHCPX vs another fund for a side-by-side view. QTHCPX alternatives are available via the screener, along with tax-loss harvesting opportunities.